Extended Data Fig. 2: Cummulative Incidence of Extracranial Progression-free Survival, with Intracranial Progression as a Competing Risk.
Competing risk analysis was performed for the 10 patients with evaluable systemic imaging. At 6 months, the proportion of patients extracranial progression free was 0.33 (90% CI: 0.14-0.54).
